(S)-tert-Butyl 3-(cyanomethyl)pyrrolidine-1-carboxylate
97%
- Product Code: 38417
CAS:
1187931-76-5
| Molecular Weight: | 210.2728 g./mol | Molecular Formula: | C₁₁H₁₈N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06738465 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the synthesis of pharmaceuticals, particularly as an intermediate in the production of active pharmaceutical ingredients (APIs). Its structure, featuring a pyrrolidine ring and a cyanomethyl group, makes it valuable for constructing more complex molecules, especially in the development of drugs targeting the central nervous system. It is often employed in asymmetric synthesis due to its chiral nature, enabling the creation of enantiomerically pure compounds. Additionally, it serves as a building block in organic chemistry research, aiding in the exploration of novel chemical reactions and pathways. Its stability and reactivity make it a preferred choice in medicinal chemistry for designing and optimizing drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿4,977.00 |
+
-
|
(S)-tert-Butyl 3-(cyanomethyl)pyrrolidine-1-carboxylate
This compound is primarily utilized in the synthesis of pharmaceuticals, particularly as an intermediate in the production of active pharmaceutical ingredients (APIs). Its structure, featuring a pyrrolidine ring and a cyanomethyl group, makes it valuable for constructing more complex molecules, especially in the development of drugs targeting the central nervous system. It is often employed in asymmetric synthesis due to its chiral nature, enabling the creation of enantiomerically pure compounds. Additionally, it serves as a building block in organic chemistry research, aiding in the exploration of novel chemical reactions and pathways. Its stability and reactivity make it a preferred choice in medicinal chemistry for designing and optimizing drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :